BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9521073)

  • 1. Differential processing of influenza nucleoprotein in human and mouse cells.
    Braud VM; McMichael AJ; Cerundolo V
    Eur J Immunol; 1998 Feb; 28(2):625-35. PubMed ID: 9521073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism.
    Rowland-Jones SL; Powis SH; Sutton J; Mockridge I; Gotch FM; Murray N; Hill AB; Rosenberg WM; Trowsdale J; McMichael AJ
    Eur J Immunol; 1993 Aug; 23(8):1999-2004. PubMed ID: 8344364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
    Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
    J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
    Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
    Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
    Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping.
    Carreno BM; Koenig S; Coligan JE; Biddison WE
    Mol Immunol; 1992 Sep; 29(9):1131-40. PubMed ID: 1379681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
    Freer G; Senesi S
    Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
    Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
    J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
    Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
    Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
    Collins EJ; Booth BL; Cerundolo V
    J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
    Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
    J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.
    Tourdot S; Oukka M; Manuguerra JC; Magafa V; Vergnon I; Riché N; Bruley-Rosset M; Cordopatis P; Kosmatopoulos K
    J Immunol; 1997 Sep; 159(5):2391-8. PubMed ID: 9278330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
    Ossevoort MA; Sijts AJ; van Veen KJ; Momburg F; Hämmerling GJ; Seelig A; Butcher GW; Howard JC; Kast WM; Melief CJ
    Eur J Immunol; 1993 Dec; 23(12):3082-8. PubMed ID: 8258321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.
    Ferris RL; Hall C; Sipsas NV; Safrit JT; Trocha A; Koup RA; Johnson RP; Siliciano RF
    J Immunol; 1999 Feb; 162(3):1324-32. PubMed ID: 9973386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
    Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
    Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.